Victorian patients gain access to world-leading cancer detection technology | Alfred Health
Victorian cancer patients are set to benefit from cutting-edge imaging technology, as The Alfred becomes the first public hospital in the state to introduce a revolutionary total-body Quadra PET scanner. This groundbreaking development marks a significant advancement in cancer care, diagnosis, and research, offering a range of benefits that will transform patient outcomes.
The Quadra PET scanner, housed within the Paula Fox Melanoma and Cancer Centre's Theranostics Service, is set to revolutionize the way cancers are detected and treated. According to Prof. Mark Shackleton, Director of Oncology at The Alfred, this technology enables early cancer detection, even before symptoms appear, leading to earlier diagnoses, safer and more personalized treatments, and improved survival rates.
One of the key advantages of the Quadra is its ability to scan the entire body simultaneously, significantly reducing radiation exposure compared to traditional PET scans. This makes the scanning process easier and safer for both patients and staff, particularly for those requiring multiple scans.
The Quadra's capabilities extend beyond cancer care. Prof. Meng Law, Director of Radiology and Nuclear Medicine at The Alfred, highlights its potential in neurological research and care. The technology drastically reduces scan times from up to an hour to just five minutes, enabling the scanning of more patients in need, more quickly, and with less discomfort. This is especially beneficial for patients with advanced cancer or neurological conditions, who often find long scan times challenging.
Furthermore, the Quadra opens new frontiers in AI-driven diagnostics and precision medicine. Its ultra-high resolution and real-time technology allow clinicians and researchers to match therapies to individual tumour biology, a field known as theranostics. This enables the delivery of cutting-edge clinical trials and the ability to adjust treatments in near-real time based on patient responses and side effects.
The technology's impact extends to Victoria's position as a global leader in theranostics. Health Minister Mary-Anne Thomas, during her visit to the Theranostics Service, witnessed the Quadra's capabilities firsthand. The scanner's development was made possible through a substantial investment of $24 million, jointly funded by the Federal Government, Victorian Government, and philanthropic support from The Alfred Foundation.
In summary, the introduction of the Quadra PET scanner at The Alfred represents a significant milestone in cancer care, offering early detection, safer scans, and personalized treatments. Its impact extends beyond cancer, revolutionizing neurological research and care, and positioning Victoria at the forefront of global innovation in theranostics.
